Emerging Nanotechnologies in Immunology - The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines (Hardcover)


Emerging Nanotechnologies in Immunology aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanophamaceuticals currently in the pipeline of S&T development for skin, ocular, and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The scientific development of manufactured nanomaterials for drug delivery is increasing rapidly. One of the most prominent applications is topical drug delivery, where cutaneous, ocular, and nasal exposure becomes even more relevant. These targets are the first barrier that nanoparticles encounter when in contact with the human body. The contributors addresses a representative set of the broad spectrum of nanopharmaceuticals currently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue engineered skin substitutes. Regulation and risk is also covered, since the safety of these nanophamaceuticals still represents a barrier to their wide innovative use.

R3,249
List Price R3,580
Save R331 9%

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles32490
Mobicred@R304pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days



Product Description

Emerging Nanotechnologies in Immunology aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanophamaceuticals currently in the pipeline of S&T development for skin, ocular, and nasal drug delivery, including absorption, toxicity, and the ability to distribute after systemic exposure. The scientific development of manufactured nanomaterials for drug delivery is increasing rapidly. One of the most prominent applications is topical drug delivery, where cutaneous, ocular, and nasal exposure becomes even more relevant. These targets are the first barrier that nanoparticles encounter when in contact with the human body. The contributors addresses a representative set of the broad spectrum of nanopharmaceuticals currently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue engineered skin substitutes. Regulation and risk is also covered, since the safety of these nanophamaceuticals still represents a barrier to their wide innovative use.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Elsevier - Health Sciences Division

Country of origin

United States

Series

Micro & Nano Technologies

Release date

May 2018

Availability

Expected to ship within 12 - 17 working days

Editors

,

Dimensions

235 x 191mm (L x W)

Format

Hardcover

Pages

290

ISBN-13

978-0-323-40016-9

Barcode

9780323400169

Categories

LSN

0-323-40016-7



Trending On Loot